Key Highlights
-
Etoricoxib demand in China is rising, driven by increased consumption in pharmaceuticals and healthcare sectors.
-
Etoricoxib supply remains stable, supported by resumed manufacturing and efficient logistics operations.
-
Etoricoxib prices are climbing steadily after months of decline, reflecting improved market balance.
-
Export interest in Etoricoxib is growing, with new inquiries emerging from western markets.
-
Global trade developments are boosting optimism for Etoricoxib, with expectations of sustained international demand.
At the demand side, the Chinese market has seen a significant boost in demand of Etoricoxib in the Chinese market due to the growth in consumption by the key sectors like pharmaceuticals and healthcare. Etoricoxib purchasing activity also increased in relation to the prior month, which is the first indication of recovery following the disappointing performance of July. The tariff truce between Washington and Beijing was extended by xx days, which helped stabilize the market, serving as a contributor to stable demand rates....
